Dermatology · Northport, AL
NPI
1538100011
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4410 Watermelon Rd
Northport, AL, 35473
Phone (205) 345-1520
Groups this clinician bills Medicare through
Medicare paid, 2024
$377K
9,375 services
Medicare patients, 2024
1,322
Average age 76
Drug cost, 2024
$4.8M
3,488 prescriptions
Company payments, 2025
$2,766
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffery C Weeks was code 17003 (destruction skin lesion), 4,326 times for 642 patients. In total Jeffery C Weeks billed 9,375 services in 68 codes, and Medicare paid $377K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-09-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 4,326 | 642 | $4.55 | $20K |
| 99213 Office E&M - Established | Office | 1,501 | 1,019 | $56.71 | $85K |
| 17000 Destruction Skin Lesion | Office | 1,097 | 804 | $33.03 | $36K |
| 17110 Destruction Skin Lesion | Office | 750 | 584 | $72.05 | $54K |
| 11102 Skin Biopsy | Office | 355 | 314 | $54.20 | $19K |
| 17004 Destruction Skin Lesion | Office | 195 | 143 | $109.96 | $21K |
| 99214 Office E&M - Established | Office | 149 | 125 | $83.34 | $12K |
| 99203 Office E&M - New | Office | 142 | 142 | $65.30 | $9,273 |
| 11103 Skin Biopsy | Office | 89 | 61 | $37.22 | $3,313 |
| 99212 Office E&M - Established | Office | 89 | 79 | $37.16 | $3,307 |
| 17262 Destruction Skin Lesion | Office | 51 | 46 | $117.01 | $5,968 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 47 | 27 | $0.69 | $32.58 |
| 17111 Destruction Skin Lesion | Office | 37 | 34 | $90.65 | $3,354 |
| 11900 Skin | Office | 37 | 25 | $26.60 | $984 |
| 17261 Destruction Skin Lesion | Office | 31 | 30 | $97.40 | $3,020 |
By year: 2022 $298K for 8,019 services; 2023 $525K for 9,096 services; 2024 $377K for 9,375 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffery C Weeks prescribed most often to Medicare patients was Doxycycline Hyclate, with 568 prescriptions and refills. In total Jeffery C Weeks wrote 3,488 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Hyclate Generic | 568 | 737 | 102 | $13K |
| Clobetasol Propionate Generic | 314 | 330 | 179 | $14K |
| Triamcinolone Acetonide Generic | 199 | 211 | 127 | $2,171 |
| Ketoconazole Generic | 187 | 199 | 88 | $3,113 |
| Ciclopirox Ciclopirox Olamine | 172 | 186 | 89 | $4,000 |
| Dupixent Pen Dupilumab | 145 | 145 | 16 | $552K |
| Ciclopirox Generic | 120 | 128 | 62 | $5,247 |
| Valacyclovir Valacyclovir Hcl | 108 | 140 | 36 | $4,134 |
| Dutasteride Generic | 100 | 187 | 25 | $2,951 |
| Hydrocortisone Generic | 97 | 97 | 65 | $918 |
| Desonide Generic | 83 | 83 | 67 | $3,123 |
| Fluconazole Generic | 76 | 110 | 34 | $462 |
| Dupixent Syringe Dupilumab | 75 | 75 | Under 11 | $276K |
| Metronidazole Generic | 75 | 87 | 33 | $7,786 |
| Skyrizi Pen Risankizumab-Rzaa | 71 | 183 | 19 | $1.4M |
Brand drugs: 651 claims; generic drugs: 2,837 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffery C Weeks $2,766 ($2,766 in general payments such as food, travel and fees) from 23 companies. The largest payer was Abbvie Inc. with $476.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 27 | $476 |
| Novartis Pharmaceuticals Corporation NVS | 28 | $377 |
| LEO Pharma Inc. | 11 | $267 |
| Regeneron Healthcare Solutions, Inc. REGN | 9 | $251 |
| Pfizer Inc. PFE | 21 | $222 |
| Arcutis Biotherapeutics, Inc. ARQT | 9 | $136 |
| Genzyme Corporation SNY | 4 | $109 |
| Janssen Biotech, Inc. JNJ | 5 | $107 |
| Lilly USA, LLC LLY | 5 | $102 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 3 | $87.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.